Vincerx Pharma Inc VINC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
0.88quote price arrow down-0.0003 (-0.0342%)
Volume
657
Close
0.8771quote price arrow down-0.0529 (-5.6882%)
Volume
299,399
52 week range
0.61 - 9.37
Loading...
  • Open0.9272
  • Day High0.935
  • Day Low0.8511
  • Prev Close0.93
  • 52 Week High9.37
  • 52 Week High Date03/11/24
  • 52 Week Low0.61
  • 52 Week Low Date12/19/23

Key Stats

  • Market Cap24.039M
  • Shares Out27.41M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-25.67

KEY STATS

  • Open0.9272
  • Day High0.935
  • Day Low0.8511
  • Prev Close0.93
  • 52 Week High9.37
  • 52 Week High Date03/11/24
  • 52 Week Low0.61
  • 52 Week Low Date12/19/23
  • Market Cap24.039M
  • Shares Out27.41M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-25.67

RATIOS/PROFITABILITY

  • EPS (TTM)-1.89
  • P/E (TTM)-0.46
  • Fwd P/E (NTM)-0.86
  • EBITDA (TTM)-42.557M
  • ROE (TTM)-136.38%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vincerx Pharma Inc

 

Profile

MORE
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing differentiated and novel therapies to address the unmet medical needs of patients with cancer. It has a next generation bioconjugation platform, called VersAptx. The VersAptx platform is a versatile and adaptable, next generation bioconjugation platform. Its product candidates include VIP943 (CD123-KSPi), VIP924 (CXCR5-KSPi), VIP236, and Enitociclib (P-TEFb/CDK9...
Ahmed Hamdy M.D.
Chairman of the Board, Chief Executive Officer
Raquel Izumi Ph.D.
President, Chief Operating Officer, Director
Alexander Seelenberger
Chief Financial Officer
Tom Thomas
General Counsel, Chief Legal Officer
Address
260 Sheridan Avenue, Suite 400
Palo Alto, CA
94306
United States

Top Peers

SYMBOLLASTCHG%CHG
LSTA
Lisata Therapeutics Inc
2.70-0.23-7.85%
PYPD
PolyPid Ltd
4.94+0.14+2.92%
SRZN
Surrozen Inc
9.61-0.49-4.85%
CNTX
Context Therapeutics Inc
1.85+0.10+5.71%
RNXT
RenovoRx Inc
1.22-0.05-3.94%